113 related articles for article (PubMed ID: 8589017)
21. Magnetic resonance imaging of bone marrow versus bone marrow biopsy in malignant lymphoma.
Ozgüroglu M; Esen Ersavasti G; Demir G; Aki H; Demirelli F; Kanberoglu K; Mandel N; Büyükünal E; Serdengeçti S; Berkarda B
Pathol Oncol Res; 1999; 5(2):123-8. PubMed ID: 10393364
[TBL] [Abstract][Full Text] [Related]
22. Malignant lymphoma: bone marrow imaging versus biopsy.
Linden A; Zankovich R; Theissen P; Diehl V; Schicha H
Radiology; 1989 Nov; 173(2):335-9. PubMed ID: 2678249
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of [18F]-FDG-Based Hybrid Imaging Combinations for Assessment of Bone Marrow Involvement in Lymphoma at Initial Staging.
Asenbaum U; Nolz R; Karanikas G; Furtner J; Woitek R; Staudenherz A; Senn D; Raderer M; Weber M; Simonitsch-Klupp I; Mayerhoefer ME
PLoS One; 2016; 11(10):e0164118. PubMed ID: 27723817
[TBL] [Abstract][Full Text] [Related]
24. The relation of bone marrow scintigraphy and unilateral bone marrow biopsy in malignant lymphoma.
Esmaili J; Safaee SR; Sharifian R; Shoeybi S; Gholamrezanezhad A
Hell J Nucl Med; 2005; 8(2):125-8. PubMed ID: 16142255
[TBL] [Abstract][Full Text] [Related]
25. Study of bone marrow cells in non-Hodgkin's lymphoma by DNA analysis.
Chen PM; Fan S; Lin SH; Tzeng CH; Liu JH; Liu JM; Yeh HM; Chiou TJ
Leuk Res; 1991; 15(12):1097-106. PubMed ID: 1662735
[TBL] [Abstract][Full Text] [Related]
26. Utilization of 18F-FDG PET/CT as a staging tool in patients with newly diagnosed lymphoma.
Cho SF; Chang CC; Liu YC; Chang CS; Hsiao HH; Liu TC; Huang CT; Lin SF
Kaohsiung J Med Sci; 2015 Mar; 31(3):130-7. PubMed ID: 25744235
[TBL] [Abstract][Full Text] [Related]
27. Bone marrow cellularity MRI calculation and correlation with bone marrow biopsy.
Matcuk GR; Siddiqi I; Cen S; Hagiya A; Isaacson R; Brynes R
Clin Imaging; 2016; 40(3):392-7. PubMed ID: 27133674
[TBL] [Abstract][Full Text] [Related]
28. Patterns of bone marrow involvement in chronic lymphocytic leukemia and small lymphocytic (well differentiated) non-Hodgkin's lymphoma. Its clinical significance in relation to their differential diagnosis and prognosis.
Pangalis GA; Roussou PA; Kittas C; Mitsoulis-Mentzikoff C; Matsouka-Alexandridis P; Anagnostopoulos N; Rombos I; Fessas P
Cancer; 1984 Aug; 54(4):702-8. PubMed ID: 6744204
[TBL] [Abstract][Full Text] [Related]
29.
Hassan A; Siddique M; Bashir H; Riaz S; Wali R; Mahreen A; Nawaz MK
Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1198-1206. PubMed ID: 28229191
[TBL] [Abstract][Full Text] [Related]
30. Bone marrow biopsy in the initial staging of Hodgkin's disease.
Doll DC; Ringenberg QS; Anderson SP; Hewett JE; Yarbro JW
Med Pediatr Oncol; 1989; 17(1):1-5. PubMed ID: 2913470
[TBL] [Abstract][Full Text] [Related]
31. Quantitative magnetic resonance studies of lumbar vertebral marrow in patients with refractory or relapsed Hodgkin's disease.
Smith SR; Williams CE; Edwards RH; Davies JM
Ann Oncol; 1991 Feb; 2 Suppl 2():39-42. PubMed ID: 2049319
[TBL] [Abstract][Full Text] [Related]
32. [The value of combined use of bone marrow smear and section in lymphoma for diagnosis and staging].
Cui P; Lou F; Fu Y
Zhonghua Nei Ke Za Zhi; 1999 Jul; 38(7):473-5. PubMed ID: 11798685
[TBL] [Abstract][Full Text] [Related]
33. The value of sequential bone marrow biopsy and laparotomy and splenectomy in a series of 200 consecutive untreated patients with non-Hodgkin's lymphoma.
Ribas-Mundo M; Rosenberg SA
Eur J Cancer (1965); 1979 Jul; 15(7):941-52. PubMed ID: 488154
[No Abstract] [Full Text] [Related]
34. Detection of bone marrow abnormalities in patients with Hodgkin's disease by T1 mapping of MR images of lumbar vertebral bone marrow.
Smith SR; Roberts N; Percy DF; Edwards RH
Br J Cancer; 1992 Feb; 65(2):246-51. PubMed ID: 1739624
[TBL] [Abstract][Full Text] [Related]
35. (18)F-FDG PET/CT bone/bone marrow findings in Hodgkin's lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging.
Moulin-Romsee G; Hindié E; Cuenca X; Brice P; Decaudin D; Bénamor M; Brière J; Anitei M; Filmont JE; Sibon D; de Kerviler E; Moretti JL
Eur J Nucl Med Mol Imaging; 2010 Jun; 37(6):1095-105. PubMed ID: 20204358
[TBL] [Abstract][Full Text] [Related]
36. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
Berthet L; Cochet A; Kanoun S; Berriolo-Riedinger A; Humbert O; Toubeau M; Dygai-Cochet I; Legouge C; Casasnovas O; Brunotte F
J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577
[TBL] [Abstract][Full Text] [Related]
37. Bone marrow involvement in malignant lymphoma without peripheral lymphadenopathy.
Staples WG; Gétaz EP
S Afr Med J; 1977 Jul; 52(2):60-3. PubMed ID: 578338
[TBL] [Abstract][Full Text] [Related]
38. Bone marrow trephine biopsy involvement by lymphoma: pattern of involvement and concordance with flow cytometry, in 10 years from a single institution.
Cabezas-Quintario MA; Gomez P; Yuste-Del Pozo V; Valencia-Mesa AL; Sosa G; Ricard P; Hijas-Gómez AI; Pinedo F; Arguelles M
Clin Transl Oncol; 2016 May; 18(5):537-40. PubMed ID: 26311078
[TBL] [Abstract][Full Text] [Related]
39. Bone marrow manifestations of peripheral T-cell lymphoma. A study of 30 cases.
Hanson CA; Brunning RD; Gajl-Peczalska KJ; Frizzera G; McKenna RW
Am J Clin Pathol; 1986 Oct; 86(4):449-60. PubMed ID: 3490173
[TBL] [Abstract][Full Text] [Related]
40. [Marrow infiltration in malignant non-Hodgkin's lymphoma (71 consecutive bone marrow biopsies)].
Bettini R; Lenotti MA; Frigerio B
Haematologica; 1982 Aug; 67(4):567-75. PubMed ID: 6815015
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
